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enriched in endothelial cells. miR-126 has been found to promote angiogenesis and inhibit
vascular inﬂammation in endothelial cells by repressing three target genes Sprouty-related
EVH1 domain-containing protein 1 (SPRED1), phosphoinositol-3 kinase regulatory subunit 2
(PIK3R2), and vascular cell adhesion molecule 1 (VCAM1). Our previous study showed that
the expression of miR-126 was downregulated after spinal cord injury (SCI). Therefore, we
wanted to examine whether upregulation of miR-126 could promote angiogenesis, inhibit
inﬂammation, and exert a positive effect on recovery after contusion SCI. In this study, we
found that increased levels of miR-126 promoted angiogenesis, and inhibited leukocyte
extravasation into the injured spinal cord, which was concurrent with downregulation of
mRNA and protein expression of three validated miR-126 target genes, SPRED1, PIK3R2, and
VCAM1. Moreover, a dose-dependent effect of miR-126 was observed in rescuing tissue
damage and improving the functional deﬁcit after SCI. Thus, the present study indicated
that miR-126 played an important role in angiogenesis and inﬂammation after SCI.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).6
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Contusive spinal cord injury (SCI) is a devastating neurological
injury that causes progressive tissue loss, secondary to vascu-
lar dysfunction and inﬂammation at the injury epicenter
(Bramlett and Dietrich, 2007; Fleming et al., 2006; Norenberget al., 2004). Endothelial cells and blood vessels at the epicenter
of the injured spinal cord show degenerative changes minutes
after a primary injury. Signiﬁcant decreases in microvascular
endothelial cells are observed subsequently because of necrotic
or apoptotic cell death (Casella et al., 2006; Dohrmann et al.,
1971). Hours later, leukocytes ﬂood into the injured spinal cord
Fig. 1 – Agomir-126 treatment reduced white matter loss following SCI. Compared to sham-operated (laminectomy only) rats
with normal white matter (A), rats injected intravenously with saline over 7 d (B) had extensive loss of white matter as shown
by myelin staining with Luxol fast blue in transverse sections at the injury epicenter. (C–E) Injection of agomir-126 at a
concentration of 4, 20, or 100 nmol/mL increased the amount of spared white matter. (F–J) Adjacent sections of A–E were
stained with hematoxylin-eosin (HE). Scale bar in (A) is 500 lm for (A–J). (K) The total white matter area at the injury epicenter
(as a percentage of sham) showed that agomir-126 treatments improved white matter sparing compared to that with the
saline at 7 d. Data are mean7SEM values. nPo0.05; nnPo0.01.
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loperoxidase (MPO) and NADPH, which provoke an inﬂamma-
tory reaction (Bao et al., 2004; Brandes and Kreuzer, 2005; Taoka
et al., 1997; Vaziri et al., 2004). Two to three days later, most
blood vessels are destroyed and are lost in the lesion epicenter
(Benton et al., 2008; Loy et al., 2002). While the surviving blood
vessels become leaky (Whetstone et al., 2003), mediating
leukocyte inﬁltration and activating macrophages that are
derived from blood-borne monocytes and resident microglia
(Donnelly and Popovich, 2008). An abundance of oxidative and
proteolytic enzymes is released and causes further tissue
damage. The injured spinal cord became swollen and edema-
tous, exacerbating the ischemia (Casella et al., 2006; Loy et al.,
2002), contributing to progressive degeneration and subsequent
functional deﬁcits (Hall and Springer, 2004; Norenberg et al.,
2004; Tator and Fehlings, 1991; Tator and Koyanagi, 1997).
Three to seven days after SCI, an angiogenic response is seen
within the epicenter gray matter, which results in minimiza-
tion of the size of the lesion and maintenance of viability;however, this responsemight be too insigniﬁcant (Benton et al.,
2008; Loy et al., 2002; Norenberg et al., 2004).
In the past few years, studies that involved promotion of
angiogenesis or attenuated the early inﬂammatory response
demonstrated improved neurobehavioral recovery after SCI
(Bethea, 2000; Gris et al., 2004; Han et al., 2010). However,
previous attempts to develop therapies were confounded by
complex mechanisms in clinical settings; nevertheless, a
satisfactory therapy has been discussed here.
MicroRNAs (miRs) constitute a class of small RNAs (approxi-
mately 20–25 nt) that regulate the expression of target mRNAs by
inhibiting translation or destabilizing target mRNA. They greatly
affect the regulation of signaling pathways that moderate
common and speciﬁc functions across different cellular pheno-
types and environments (Wu and Belasco, 2008; Zhao and
Srivastava, 2007). miR-126 is a microRNA that is highly enriched
in endothelial cells (Harris et al., 2008). Previous studies found
that miR-126 plays an important role in vascular integrity and
can promote angiogenesis during embryonic development and
Fig. 2 – Agomir-126 treatment provided lasting improvement
in locomotor function following SCI in rats. After SCI, rats
were intrathecally treated with saline, negative control (NC),
and agomir-126 at a concentration of 4, 20, or 100 nmol/mL
b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 – 2 0 2 193after injury (Fish et al., 2008; van Solingen et al., 2009;Wang et al.,
2008). miR-126 was also found to inhibit vascular inﬂammation
by targeting an intercellular adhesion molecule that mediated
leukocyte inﬁltration (Harris et al., 2008). However, the speciﬁc
roles of miR-126 in SCI have not yet been investigated.
Our previous study found that the expression of miR-126
decreased after SCI (Hu et al., 2013). Therefore, in this study,
we wanted to examine whether upregulation of the level of
miR-126 could promote angiogenesis, inhibit inﬂammation,
and exert a positive effect on recovery after contusion SCI. A
previous study found that the angiogenic response within the
epicenter gray matter diminished and disappeared concur-
rently with cystic cavity formation; therefore, therapies
targeting angiogenic processes should be directed at the
subacute interval after SCI (Loy et al., 2002). Therefore, we
limited our intervention to 7 d to reduce the potential detri-
mental side effects of miR-126, which could occur at the
same time.for 7 d. Hind limb recovery was assessed from 1 to 28 d after
SCI by using BBB scoring. Bars represent means7SEM.
nPo0.05, nnPo0.01 compared to saline.2. Results
2.1. miR-126 reduced white matter loss following SCI
We determined effective doses of agomir-126 using white matter
sparing at the epicenter as a measure because it correlates with
locomotor function. Transverse sections in series of adjacent
sections were used for measurements of white matter sparing
and histological staining across all experiments. The injury
epicenter was determined by the minimum area of myelin along
the spinal cord axis. Compared to sham-operated (laminectomy
only) rats with normal white matter (Fig. 1A), rats treated with
saline for 7 d (Fig. 1B) showed extensive loss of the ventral white
matter after injury. In agomir-126-treated groups, much of the
ventral and lateral white matter was spared (Fig. 1C–E). The
white matter area at the epicenter was greatly spared with
agomir-126 at 4, 20, or 100 nmol/mL than with saline at 7 d post-
injury (Fig. 1K). Intrathecal injections of miR-126 over 7 d at
concentrations of 4, 20, or 100 nmol/mL showed that signiﬁcantly
better protection of white matter was obtained at 20 nmol/mL
than at 4 nmol/mL and that the 100 nmol/mL dose did not
further improve the outcome (Fig. 1K). Histological changes were
visualized by HE staining of adjacent sections (Fig. 1F–J).
2.2. miR-126 reduced locomotor deﬁcits following SCI
miR-126 was tested for its effects on rescuing overground
locomotion by using the BBB score (Fig. 2). After SCI, all rats
were paralyzed in both hind limbs. Spontaneous recovery of
function after SCI was observed among groups.
Signiﬁcant difference in functional testing among groups was
not observed until 7 d; at that time, following SCI, rats adminis-
tered intrathecal injections of agomir-126 at a concentration of
4, 20, or 100 nmol/mL showedmore elevated locomotor recovery
than the saline- or negative control-treated groups. Rats treated
with agomir-126 at a concentration of 20 or 100 nmol/mL
showed signiﬁcantly better protection of white matter than
those treated with the 4 nmol/mL dose, and there was no
statistical signiﬁcance between the 20 and 100 nmol/mL groups.
These results correlated well with the results of epicenter whitematter sparing. A beneﬁcial effect of miR-126 was also seen at 14
and 21 d and it was observed to last until 28 d. No statistically
signiﬁcant difference was observed between the saline-treated
group and the negative control-treated group over 4 weeks of
observation. Therefore, we used 20 nmol/mL agomir-126 for the
subsequent experiments.
2.3. miR-126 improved vascularity at the injury site
We used FITC-LEA to determine the presence of perfused
blood vessels at the epicenter, as LEA only binds to the
endothelial cells of perfused blood vessels. Twenty-four
hours after SCI, compared to the results for the sham-
operated rats (Fig. 3A), the number of LEA-labeled blood
vessels around the epicenter greatly decreased in negative
control and agomir-126-treated rats (Fig. 3B and E); further-
more, agomir-126-treated rats had more blood vessels than
negative control-treated rats, although this difference was
not statistically signiﬁcant (P¼0.08). Seven days after injury,
the blood vessels in rats treated with the negative control did
not increase (P40.05) (Fig. 3C). However, in agomir-126
treated rats, there was a signiﬁcant increase in blood vessels
at 7 d (Fig. 3G) compared to that at 24 h (Po0.05); more blood
vessels were found in agomir-126 treated rats than negative
control rats after 7-d treatment (Po0.01) (Fig. 3G).
2.4. miR-126 reduced inﬂammation after SCI
Inﬂammation contributes to tissue damage after SCI. In this
study, CD45 was used as a marker for extravasated leuko-
cytes, and CD68 was used as a marker for activation of
resident microglia and extravasated macrophages, which
are major contributors to demyelination (Gris et al., 2004;
Popovich et al., 1999; Shuman et al., 1997).
In this study, three consecutive sections at 1-mm distances
spanning 3mm rostral to 3mm caudal from the epicenter were
selected for staining. Samples from the sham-operated rats
Fig. 3 – Agomir-126 treatments improved vascularity after SCI. (A) LEA-labeled blood vessels in sham-operated rats had a
normal appearance. (B) At 24 h following spinal cord injury, rats treated with the negative control (NC) had few blood vessels.
(C) At 7 d after injury, rats treated with the negative control did not show an increase in blood vessels. (D) The inset box
represents the region shown in A–C, E, and F. (E) Rats treated with agomir-126 for 24 h had more blood vessels, although this
difference was not statistically signiﬁcant (P¼0.08). (F) Rats treated with agomir-126 for 7 d had a signiﬁcant increase in blood
vessels. Scale bar in (A) is 100 lm for (A–C, E, F). Data are mean7SEM. (G) The total area of blood vessels at the injury epicenter
(as a percentage of sham) showed that agomir-126 treatments improved vascularity after injury. nPo0.05; nnPo0.01. dc: dorsal
column, dh: dorsal horn.
b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 – 2 0 2194showed little or no immunostaining for CD45 and CD68 (Fig. 4A
and F). Twenty-four hours after SCI, there was no statistical
signiﬁcance between the negative control- and agomir-126-
treated groups (data not shown). Seven days after injury,
samples from rats treated with the negative control showed
abundant CD45-positive cells throughout the epicenters of the
spinal cords (Fig. 4B and C) and in cells both rostral and caudal to
it. This inﬁltration was markedly attenuated by agomir-126
(Fig. 4D and E). Similar results were observed with CD68
immunostaining (Fig. 4G–K). Peripheral leukocyte numbers were
within the normal range in both the negative control and
agomir-126 treated groups, at 7 d post-injury (Table 2).
2.5. The levels of three target genes were changed after
miR-126 treatment
SPRED1, PIK3R2, and VCAM1 are three validated target genes of
miR-126. Previous studies found that miR-126 promotes angio-
genesis by repressing SPRED1 and PIK3R2, and miR-126 could
also inhibit vascular-related inﬂammation by repressing VCAM1
expression post-transcriptionally (Fish et al., 2008; Harris et al.,
2008; Wang et al., 2008).In our study, the level of miR-126 decreased at 1, 3, and 7 d
after SCI (Fig. 5A). After 7 d treatment with agomir-126, the level
of miR-126 in spinal cord increased (Fig. 6). To explore the
possible mechanism underlying the effect of miR-126 on SCI,
we examined mRNA levels of miR-126 target genes and
corresponding protein levels using qRT-PCR and Western blot-
ting after agomir-126 treatment. The mRNA levels of two target
genes, SPRED1 and PIK3R2, at 1, 3, and 7 d after SCI were lower
than those of sham-operated rats (Fig. 5B and C). Protein levels
of these two targets correlated well with the mRNA changes
(Fig. 7A). The mRNA and protein levels of these two genes
sharply decreased at 1, 3, and 7 d after agomir-126 treatment
compared to those with negative control-treated rats.
The mRNA level of another target of miR-126, VCAM1, was
elevated on 1, 3, and 7 d after SCI (Fig. 5D). The mRNA level of
VCAM1 at 3 and 7 d was lower after treatment with miR-126
agomir than in the negative control-treated groups (Fig. 5D).
However, we could not detect VCAM1 protein in either
negative control or miR-126 agomir-treated groups. This lack
of detection was not due to an ineffective antibody, since
VCAM1 protein was detectible in positive control tissue (data
not shown).
Fig. 4 – Agomir-126 treatment reduced inﬂammation after SCI. (A) A transverse section through the entire spinal cord at the
injury epicenter stained for CD45 showed no or little inﬁltration of leukocytes at 7 d in sham-operated rats. (B) Rats treated
with the negative control (NC) for 7 d showed extensive inﬁltration of leukocytes post-injury. (D) Treatment with agomir-126
greatly reduced the inﬁltration. (C) and (E) are dual-stained, higher magniﬁcation images of (B) and (D) with 40,6-diamidino-2-
phenylindole dihydrochloride (DAPI). (G and I) CD68, a marker for activated microglia and macrophages, was similarly
reduced by agomir-126. (F) Sham-operated rats exhibited no or little immunostaining. (H) and (J) are dual-stained higher-
magniﬁcation images of (G) and (I) with DAPI. Scale bar in (I) is 500 lm for (A, B, D, F, and G), and scale bar in (J) is 50 lm for (C,
E, and H). (K) The total cross-sectional area of CD45-positive cells at the injury site showed that agomir-126 treatments
reduced inﬁltration compared to that for the negative control at 7 d post-injury. The area was the sum of areas at 1 mm
distance within a segment from 3mm rostral to 3 mm caudal to the epicenter and was seen as a percentage of the negative
control group within the experiment. The cross-sectional area of CD68-positive cells at the injury site showed that agomir-126
treatments reduced microglia/macrophage activation at all post-injury times. Data are mean7SEM values. nPo0.05; nnPo0.01
compared to the negative control.
b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 – 2 0 2 195We measured the phosphorylation status of ERK and AKT,
two respective downstream targets of MAP and PI3 kinase
pathways which can be activated by vascular endothelial
growth factor stimulation. We found that the phosphoryla-
tion of ERK and AKT were lower than those of sham-operated
rats at 7 d after SCI (Fig. 8). Compared with the results for the
negative control, treatment with agomir-126 increased phos-
phorylation of ERK (p-ERK) and AKT (p-AKT) at 7 d (Fig. 8).3. Discussion
In accordance with the results of our previous study (Hu et al.,
2013), we found that the expression of miR-126 was down-
regulated after SCI. Furthermore, in this study, we found that
overexpression of miR-126 promoted angiogenesis, and inhibited
leukocyte extravasation into the injured spinal cord, which was
concurrent with downregulation of the mRNA and protein levels
of three validated target genes of miR-126, SPRED1, PIK3R2, andVCAM1. Moreover, a dose-dependent effect of miR-126 was
observed while rescuing tissue damage and improving the
functional deﬁcit after SCI. Thus, the present study indicated
that miR-126 plays an important role in angiogenesis and
inﬂammation after SCI.
miR-126 is a microRNA that is highly enriched in endothe-
lial cells (Harris et al., 2008). miR-126, which is located in
intron 7 of the EGF-like domain 7 (EGFl7) gene (Musiyenko
et al., 2008), is regulated by the transcription factors Ets-1 and
Ets-2 in endothelial cells (Harris et al., 2010). Previous studies
found that miR-126 promoted stabilization and maturation of
growing blood vessels by regulating angiopoietin-1 signaling
(Sessa et al., 2012) and by repressing the p21-activated kinase
1 gene (Zou et al., 2011). miR-126 has been found to promote
angiogenesis during embryonic development and after injury
by targeting coding mRNAs of SPRED1 and PIK3R2, that is,
inhibitors of angiogenic and cell survival signals in response
to vascular endothelial cell growth factor (VEGF). Knockdown
of miR-126 during zebraﬁsh and mice embryogenesis has
Fig. 5 – Agomir-126 increased mRNA expression of SPRED1, PIK3R2, and VCAM1. (A) The expression of miR-126 decreased at
3 d and 7 d post-injury compared to the sham. (B–D) The mRNA expression of SPRED1, PIK3R2, and VCAM1 after SCI was
detected by qRT-PCR in samples collected from agomir-126 rats and negative control (NC) rats (n¼4 per time point,
respectively). Compared to the results for the negative control, treatment with agomir-126 signiﬁcantly decreased SPRED1 and
PIK3R2 expression at 1, 3, and 7 d. The expression of VCAM1 also decreased at 3 d and 7 d post-injury. Data are means7SEM
values. nPo0.05, nnPo0.01.
Fig. 6 – Agomir-126 increased mRNA expression of miR-126.
The expression of miR-126 decreased at 7 d post-injury
compared to the sham. After 7 days treatment with agomir-
126 (20 nmol/mL), the level of miR-126 in spinal cord
increased. Data are means7SEM values. nPo0.05, nnPo0.01.
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collapsed blood vessels, widespread hemorrhages, and partial
embryonic lethality (Fish et al., 2008; Wang et al., 2008).
Moreover, mice treated with a high dose of antagomir-126
have been found to exhibit a markedly reduced angiogenic
response after ischemia of the left hind limb (van Solingen
et al., 2009).
In the current study, the number of blood vessels in the
epicenters of injured spinal cords sharply decreased 24 h
after SCI in rats, more blood vessels were observed at theinjury site at 24 h post-SCI for rats treated with agomir-126
than for the negative control group; however, this difference
was not statistically signiﬁcant (Student’s t-test, P¼0.08). At
7 d after SCI, no increase was observed in the number of
blood vessels in the epicenters of injured spinal cords after 7-
d treatment with the negative control, which is similar to the
natural recovery process. Rats that were treated with agomir-
126 for 7 d had a large increase in the number of blood vessels
at the epicenter, numerous vessels reappeared in the dorsal
column of injured spinal cord (Fig. 3F), where the vessels were
lost 1 day after injury (Fig. 3E), suggesting that miR-126 could
promote angiogenesis after SCI, as it does in vitro (Fish et al.,
2008; Wang et al., 2008). Collectively, these data suggest that
miR-126 promotes therapeutic angiogenesis following SCI.
A previous study found that overexpression of miR-126
inhibited mRNA and protein expression of PI3KR2 and
SPRED1 in endothelial cells (Fish et al., 2008). SPRED1 is a
member of the sprouty and sprouty-related protein family,
which are negative regulators of growth factor signaling
(Wakioka et al., 2001). By binding and inactivating RAF1, an
upstream kinase in the MAP kinase pathway, SPRED1 func-
tioned as a membrane-associated suppressor of growth
factor-induced ERK activation and blocked cell proliferation
and migration in response to growth factor signaling, which
are processes important for angiogenesis (Miyoshi et al., 2004;
Nonami et al., 2004; Taniguchi et al., 2007). SPRED1 could also
regulate the cytoskeleton organization (Johne et al., 2008;
Miyoshi et al., 2004), a mechanism responsible for vasculature
stabilization. PIK3R2 negatively regulated the activity of PI3
Fig. 7 – Agomir-126 decreased protein levels of SPRED1 and PIK3R2. After SCI, the protein levels of SPRED1 and PIK3R2 were
detected by Western blot (A) in samples collected from agomir-126 rats and negative control (NC) rats (n¼4 per time point,
respectively), and the intensity of each band was estimated by densitometric analysis (B). Compared with the results for the
negative control, treatment with agomir-126 decreased SPRED1 levels at 1, 3, and 7 d. The PIK3R2 level at 3 d and 7 d post-
injury also decreased after agomir-126 treatment, compared to the results for the negative control. Data are means7SEM
values. nPo0.05, nnPo0.01.
Fig. 8 – Agomir-126 increased protein levels of pERK and pAKT. After SCI, the protein levels of pERK/ERK and pAKT/AKT were
detected by Western blot in samples collected from agomir-126 rats and negative control (NC) rats (n¼4 per time point,
respectively). Compared with the results for the negative control, treatment with agomir-126 (20 nmol/mL) increased
phosphorylation of ERK (p-ERK) and AKT (p-AKT) at 7 d. Data are means7SEM values. nPo0.05, nnPo0.01.
b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 – 2 0 2 197kinase, a kinase important in the Akt pathway, which is
related to an antiapoptotic effect (Ueki et al., 2003).
ERK and AKT are two respective downstream targets of MAP
and PI3 kinase pathways which can be activated by vascular
endothelial growth factor stimulation. In the current study, we
found that the phosphorylation of ERK and AKT were decreased
after SCI. Treatment with agomir-126 increased phosphorylationof ERK and AKT. We also found that the expression of SPRED1
and PIK3R2 were sharply decreased after agomir-126 treatment.
Thus, these ﬁndings suggest that miR-126 could moderate the
expression of these genes after SCI. Further studies should be
done to get deep insight into the mechanisms of miR-126 and
its target genes after SCI. We also observed an interesting
phenomenon in which expression level of the miR-126 and its
Table 1 – Biological replicates (number of rats) in each of
the experiments.
Experiment Control n Treatment n
7-Day injury (LFB,HE) Sham 4 Agomir:3 dose 12
Saline 4
28-Day injury (BBB) Sham 6 Agomir:3 dose 18
Saline 6 Negative
control
6
1-Day injury (FITC-
LEA)
Agomir 4
Negative
control
4
7-Day injury (FITC-
LEA)
Sham 4 Agomir 4
Negative
control
4
1-Day injury (IF) Agomir 4
Negative
control
4
7-Day injury (IF) Sham 4 Agomir 4
Negative
control
4
1-Day injury (PCR,
WB)
Agomir 8
Negative
control
8
3-Day injury (PCR,
WB)
Agomir 8
Negative
control
8
7-Day injury (PCR,
WB)
Sham 8 Agomir 8
Negative
control
8
LFB: Luxol fast blue staining for detecting myelin in white matter
tracts at 7 d post-injury.
HE: Hematoxylin-eosin staining to detect pathological changes at
7 d after injury.
BBB: Basso, Beattie, and Bresnahan score for measuring hind limb
locomotor function; BBB scores were measured at 1, 3, 7, 14, 21,
and 28 d post-injury.
FITC-LEA: Fluorescein isothiocyanate-conjugated Lycopersicon escu-
lentum agglutinin lectin for detecting blood vessel density at 1 and
7 d post-injury.
IF: Immunoﬂuorescence staining for analyzing the marker of
leukocytes (CD45) and the marker of activated microglial/macro-
phages (CD68) at 1 and 7 d post-injury.
PCR: Real-time ﬂuorescence quantitative RT-PCR for determining
the levels of miR-126 and mRNA of its target genes SPRED1, PIK3R2,
and VCAM1 at 1, 3, and 7 d post-injury.
WB: Western blot analysis for quantifying the protein levels of
SPRED1, PIK3R2, VCAM1, AKT, pAKT, ERK and pERK post-injury.
b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 – 2 0 2198target genes SPRED1 and PIK3R2 all decreased after SCI, suggest-
ing that themodulation of SPRED1 and PIK3R2 in SCI may involve
multiple mechanisms in addition to miR-126. Therefore, more
work should be performed to gain insights into the exact
mechanism controlling SPRED1 and PIK3R2 expression.
Therapies enhancing angiogenesis may have differing out-
comes. Some researchers found that treatment with VEGF, a
factor enhancing angiogenesis, improved the functional out-
come and decreased secondary degeneration after SCI (Liu
et al., 2010; Widenfalk et al., 2003). Other researchers found
that therapies promoting angiogenesis by activating Notch
signaling had no effect on hind limb locomotor recovery after
SCI (Fassbender et al., 2011). Some studies have even reported
that therapies enhancing angiogenesis have detrimental effects
that exacerbate tissue damage and vascular permeability
(Benton and Whittemore, 2003; Patel et al., 2009). In this study,
the current data contribute evidence to the idea that combining
angiogenesis with vascular stabilization may have potential
therapeutic applications following SCI, which correlates with
other studies (Han et al., 2010; Herrera et al., 2010).
In addition to promoting angiogenesis, miR-126 also has
anti-inﬂammatory activity. VCAM1 is an adhesion molecule
expressed by activated endothelial cells, which mediate
leukocyte adherence to endothelial cells (Alon et al., 1995;
Osborn et al., 1989). By suppressing VCAM1 expression, miR-
126 activity decreases leukocyte interactions with endothelial
cells and attenuates vascular inﬂammation after injury
(Asgeirsdottir et al., 2012; Harris et al., 2008). In the current
study, rats treated with the negative control had abundant
leukocytes and activated microglia/macrophages at the epi-
center of the injured spinal cord on the 7th day. Reduced
leukocyte inﬁltration and inﬂammation responses were seen
after treatment with agomir-126 for 7 d, which suggests that
miR-126 could inhibit leukocyte inﬁltration and reduce
inﬂammation after SCI. The expression of VCAM1 decreased
after agomir-126 treatment, which suggests that miR-126 can
moderate VCAM1 expression in an SCI model.
Inﬁltrating leukocytes and inﬂammatory cells may act
counter-productively after SCI. Apart from the detrimental
effects of some leukocytes, such as the early arriving neutro-
phils and activated macrophages (Donnelly and Popovich, 2008;
Weaver et al., 2005), inﬁltrating leukocytes such as the M2-type
macrophages showed beneﬁcial effects that promoted cell
survival and regeneration after SCI (Kigerl et al., 2009). Thus,
further work should be performed to better understand the
effects of miR-126 on sub-classes of these cells.
Depending on the different cell types and the local environ-
ment, expression and signaling of miR-126 may vary greatly.
Apart from these ﬁndings described above, miR-126 was found
in neurons (Kim et al., 2014a, 2014b) and could target other
pathways such as IGF-1 signaling, which may promote neurite
sprouting, synapse formation, and neuronal survival in the
central nervous system (Ryu et al., 2011; Zhang et al., 2008).
Thus, more research should be focused on this area.
In conclusion, in this study, we found that miR-126
expression decreased after SCI, but that increasing the levels
of miR-126 rescued more white matter, promoted angiogen-
esis, reduced inﬂammation, and improved function deﬁcit,
which was concurrent with downregulation of expression of
SPRED1, PIK3R2, and VCAM1 target genes; however, moreresearch needs to be performed to understand the exact
mechanisms underlying the effect of miR-126 in SCI.4. Experimental procedures
4.1. Animals and overall design
A total of 152 Sprague Dawley (SD) male rats were used
(weight, 180–220 g; Central South University, Hunan Province,
China) and were age- and weight-matched between groups
Table 2 – Agomir-126 and negative control did not affect leukocyte counts.
Normal range Saline Negative control Agomir-126
Leukocytes total (109/L) 1.8–11.8 5.2570.82 5.6270.69 6.1771.08
Neutrophils (109/L) 0.1–3.2 1.5770.24 1.6670.33 1.5170.28
Lymphocytes (109/L) 0.9–9.8 4.3370.69 4.8271.03 4.2770.83
Monocytes (109/L) 0.0–0.5 0.270.03 0.370.02 0.270.03
Eosinophils (109/L) 0.0–0.2 0.170.03 0.170.02 0.170.02
Basophils (109/L) 0.0–0.2 0.170.02 0.170.02 0.170.02
Erythrocytes (1012/L) 6.04–11.1 7.3271.23 7.8370.83 8.1771.17
Thrombocytes (109/L) 276–1102 6277173 7287105 6537132
Rats were treated with saline, negative control or agomir-126 (n¼8) for 7 days after spinal cord injury and 1 mL blood was drawn from the
heart for blood cell analysis before perfusion-ﬁxation. Low red blood cell counts are probably due to bleeding caused by surgery. Data are
mean7SEM values.
b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 – 2 0 2 199within an experiment. All animal procedures were approved
by the Laboratory Animal Users Committee of Central South
University.
An overview of all experimental groups is presented in
Table 1. We ﬁrst determined whether upregulating miR-126
with agomir-126 could decrease the extent of injury and
optimal dose for protecting white matter at 7 d post-injury.
A dose-response study for white matter rescue was per-
formed at the same time. Next, we determined whether a
7-d treatment with agomir-126 would improve locomotor
function over 4 weeks. Additional groups of rats were used
to investigate the effects and mechanisms of miR-126 on
vascular and inﬂammatory responses at 1, 3, and 7 d.
All surgeries, behavioral measurements, and quantiﬁca-
tion of histological results were performed by testers blinded
to the treatments. Treatments were assigned in a rando-
mized order and were prepared by someone other than the
surgeon.
4.2. Surgery
Rats were anesthetized by intraperitoneal injection of 0.3 mg/g
body weight chloral hydrate (Kermel, Tianjing, China), and their
backs were shaved and cleaned. After a midline incision and
laminectomy at vertebral level T9/T10, spinal cord contusions
were induced using a modiﬁed Allen’s weight drop apparatus
(8 g weight at a vertical height of 40 mm, 8 g40mm). A partial
laminectomy at T12/T13 was performed for the placement of
an intrathecal catheter. miR-126 agomir and miR-126 agomir
negative control (NC) were from RiboBio (Guangzhou, China). In
brief, the agomir-126 (50-UCG UAC CGU GAG UAA UAA UGC G-
30) or agomir-126 negative control (50-UCA CAA CCU CCU AGA
AAG AGU AGA-30), which was dissolved in saline (0.9%), was
continuously delivered (1 μL/h) into the intrathecal space using
subcutaneously implanted osmotic mini-pumps (Alzet 1030D,
CA, USA) connected to a subdural-implanted catheter, as
previously described (Liebscher et al., 2005). Each pump was
primed overnight at 37 1C to ensure immediate delivery after
implantation. After the implantation, muscles were sutured in
layers, the skin incision was closed with 3-0 silk threads, and
5mL of lactated Ringer’s solution was administered intraper-
itoneally. All surgeries were performed in a warm environment
to maintain body temperature. After the surgery, rats were
placed on fresh dry cages and given free access to food and
water. Penicillin G (40,000 u, i. m.) was administered daily for3 d to prevent infection. Bladders were manually expressed
twice daily until full voluntary or autonomic voiding was
obtained.
To determine the effects of miR-126 on the number of
peripheral leukocytes, 1 mL of blood was drawn from the
heart just before perfusion-ﬁxation in rats that had been
treated with negative control or agomir-126 for 7 d. Blood
counts were performed with an automated hematology
analyzer (Beckman Coulter, USA).
4.3. Functional testing
Functional recovery after SCI was determined at 1, 3, 7, 14, 21,
and 28 d post-injury by two independent and well-trained
testers blinded to treatment, using open-ﬁeld overground
locomotor performance according to Basso, Beattie, and Bres-
nahan (BBB) scores (Basso et al., 1995). The ﬁnal score for each
animal was obtained by averaging the values from both testers.
Rats with perineal infections, wounds in the limbs, or tail and
foot autophagia were excluded from the test.
4.4. Histological procedures
Rats were perfused transcardially with phosphate-buffered
saline followed by 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4). Subsequently, the spinal cords were carefully
dissected out, and 10-mm segments containing the injury site
were post-ﬁxed for 24 h at 4 1C.
To detect myelin in white matter tracts, 1 of every 5 of the
transverse sections at each rostro-caudal 1-mm level was
stained with Luxol fast blue, as previously described (Han
et al., 2010). After ﬁxation, spinal cords were embedded in
parafﬁn, sectioned at 5-mm thickness, and then mounted onto
charged microscope slides for further use. Slides were placed
in xylene at room temperature for two 20-min periods,
passed through graded ethanol solutions (twice each in
100% and 95% ethanol, once in 70% ethanol, and twice in
double-distilled H2O), and stained with 0.1% Luxol fast blue in
0.5% glacial acetic acid and 95% ethyl alcohol overnight at
56 1C. Next, the slides were gently washed in 95% ethanol to
rinse off excess stain and then brieﬂy rinsed in double-
distilled water. The slides were differentiated in 0.05%
lithium carbonate solution, differentiated in 70% ethanol,
brieﬂy rinsed in double-distilled water, dehydrated brieﬂy
through graded ethanol solutions, cleared through xylene,
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each rat on the basis of the rostro-caudal level that contained
the least amount of spared myelin per transverse section, to
align all the histological measurements for each rat. Adjacent
sections were stained with hematoxylin-eosin (HE) staining.
To label the perfused blood vessels, the jugular vein
was exposed and injected with 500 mg/250 mL ﬂuorescein
isothiocyanate-conjugated Lycopersicon esculentum aggluti-
nin lectin (LEA; Sigma, USA) at 30 min before euthanasia.
After intravenous injection, LEA binds only to endothelial
cells of perfused blood vessels (Mazzetti et al., 2004),
allowing for simultaneous detection of endothelial cell
survival in perfused blood vessels. Ten consecutive 30-μm
transverse sections per millimeter along the spinal cord
axis were cut and mounted onto charged microscope slides
for further detection.
To detect immunoﬂuorescent staining of CD45 (leukocytes)
and CD68 (activated microglia/macrophages), spinal cords were
placed in 30% phosphate-buffered sucrose overnight at 4 1C
after ﬁxation. Twenty consecutive 10-mm transverse sections at
each 1-mm rostro-caudal level along the spinal cord axis were
cut on a cryostat and thaw-mounted onto charged microscope
slides. The sections were stored in sequence at –20 1C for
further use. Slides were warmed for 30 min on a slide warmer,
a ring of wax was applied around the sections with a PAP pen
(Zsbio, Beijing, China), and the slides were rinsed in 0.1 M Tris-
buffered saline (TBS) for 15min. After blocking non-speciﬁc
staining with 10% donkey serum in TBS containing 0.3% Triton
X-100 for 1 h at room temperature, sections were incubated
overnight at 4 1C in TBS, containing 5% donkey serum, mouse
anti-CD45 (1:100; catalog number 05-1410, Millipore, Temecula,
CA, USA), and mouse anti-CD68 (1:100; catalog number
MCA341GA, ABD Serotec, Kindlington, Oxford, UK). Puriﬁed rat
immunoglobulin G (IgG) was used as a control at the same
concentrations instead of the primary antibody. Next, the
sections were incubated in TBS-Triton containing 5% donkey
serumwith secondary antibodies (1:400; Jackson, USA) for 1 h at
room temperature. Subsequently, sections were stained with
40,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Sigma,
D9542, USA) for 10 min at room temperature. Finally, the
sections were cover-slipped with antifade Gel/Mount aqueous
mounting media (Beyotime, Shanghai, China). Between steps,
sections were washed 3 times for 10 min in TBS. For normal-
izing all histological measurements, four sham-operated rats
received a laminectomy only and were analyzed 7 d later.
4.5. Real-time polymerase chain reaction
From 10-mm long spinal cord segments containing the injury
epicenter, total RNA was extracted with TRIzol (Invitrogen, CA,
USA) according to manufacturer’s instructions. To analyze
microRNA expression by quantitative real-time PCR (qRT-PCR),
RNA was reverse-transcribed using microRNA-speciﬁc primers
from RiboBio. Real-time PCR was performed on diluted samples
with miR-U6 as an internal control. For quantiﬁcation of mRNA
expression, ﬁrst-strand synthesis was performed using a Prime-
Script RT reagent kit (TaKaRa, Tokyo, Japan). Primers were
designed and supplied by Sangon Biotech (Shanghai, China).
Gene expression changes were quantiﬁed using the delta-delta
CT method. The expression of GAPDH was used as an internalcontrol. Reverse transcription (RT) reactions was performed on
the Applied Biosystems 9700 Thermocycler using the Prime-
Script RT reagent Kit (TaKaRa, Tokyo, Japan) at 37 1C/42 1C for
15min and 85 1C for 5 s. Real-time PCR reactions were con-
ducted on the iCycler iQ Real-time detection System (Bio-Rad) at
95 1C for 30 s, followed by 40 cycles each of 95 1C for 5 s and 60 1C
for 30 s, using SYBR Premix Ex Taq (TaKaRa, Tokyo, Japan).4.6. Western blot
Rats were euthanized with an overdose of chloral hydrate. After
the animals (n¼4 per group) were sacriﬁced, 10-mm long
segments of spinal cord encompassing the injury site were
then harvested for Western blot analyses. Protein concentra-
tions were determined using a bicinchoninic acid (BCA) protein
assay kit (Beyotime, Shanghai, China). Each protein sample (30
μg) was loaded for the assay. Nonspeciﬁc bands were blocked in
TBS-T (25 mM Tris (Sigma), 150 mM NaCl, 0.05% Tween 20, pH
7.5) containing 5% non-fat milk for 1 h at room temperature.
Membranes were subsequently incubated with the primary
antibodies of rabbit anti-Sprouty-related EVH1 domain-
containing protein 1 (SPRED-1) polyclonal antibody (1:200;
ab77079, Abcam, USA), rabbit anti-phosphoinositol-3 kinase
regulatory subunit 2 (PIK3R2) polyclonal antibody (1:200;
ab131067, Abcam), rat anti-vascular cell adhesion molecule 1
(VCAM1) monoclonal antibody (1:50; ab78712, Abcam), rabbit
anti-ERK1/2 polyclonal antibody (1:100; Abcam), rabbit anti-
phospho-ERK1/2 (Thr202/Tyr204) antibody (1:200; Cell Signal-
ing), rabbit anti-AKT1/2/3 polyclonal antibody (1:100; Abcam),
rabbit anti-phospho-AKT1/2 antibody (1:200; Cell Signaling) at
4 1C and followed by anti-mouse IgG horseradish peroxidase
conjugate secondary antibody (1:2000; Jackson) for 1 h at room
temperature. The immunocomplexes were visualized by che-
miluminescence using an ECL kit (Beyotime, Shanghai, China).
The ﬁlm signals were digitally scanned and then quantiﬁed
using the Quantity One 4.6.2 software (Bio-Rad, USA). An
antibody for GAPDH (1:35,000; Sigma, USA) was used as an
internal control. Data have been provided in terms of the
mean7SD of the percentage ratio of the control.4.7. Statistics
All data were analyzed using the IBM SPSS 19.0 statistical
software. Two-way repeated measures ANOVA with the post-
hoc Tukey test was used to analyze the differences in BBB
scores among groups over time. Statistically signiﬁcant differ-
ences between two groups were determined by a two-tailed t-
test. One-way ANOVA followed by post-hoc Tukey analysis was
performed to compare groups of three or more. In cases where
data were not normally distributed, the Kruskal–Wallis test was
used. A value of Pr0.05 was considered statistically signiﬁcant.
Values are presented as mean7SEM.Acknowledgments
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